Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
  1. 4 Planned sale EXEC. VP AND CLO sold 3,395 shares at an average $28.85 ($97,960)
  2. 4 Planned sale CHIEF TECHNICAL OPS OFFICER sold 2,910 shares at an average $28.85 ($83,950)
  3. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 10,107 shares at $27.15 ($274,393)
  4. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 75,000 shares (grant or award)
  5. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 7,700 shares at $25.81 ($198,736)
  6. 4 Open-market sale Director sold 11,666 shares at an average $39.86 ($464,972)
  7. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 26,000 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale Director sold 1,000 shares at $44.86 ($44,860)
  11. 4 Grant or award Director acquired 6,333 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Planned sale Director sold 9,768 shares at an average $59.53 ($581,515)
  14. 4 Planned sale CHIEF BUSINESS OFFICER sold 8,416 shares at an average $58.97 ($496,282)
  15. 4 Planned sale CHIEF BUSINESS OFFICER sold 8,836 shares at an average $58.52 ($517,089)
  16. 4 Planned sale Director sold 23,000 shares at an average $55.08 ($1,266,930)
  17. 4 Planned sale SVP, FINANCE & CAO sold 4,692 shares at an average $55.06 ($258,326)
  18. 4 Planned sale Director sold 4,328 shares at an average $55.05 ($238,258)
  19. 4 Planned sale CHIEF BUSINESS OFFICER sold 732 shares at $52.04 ($38,096)
  20. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 1,211 shares at $52.04 ($63,025)

Page 10 of 31 · 618 filings